Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitors
US7919502B2 · kind B2 · utility
8Cited by
10References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2009 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Sep 24, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of Formula Ior a pharmaceutically acceptable salt form thereof, wherein A, L1, R1, R2, R3, R4, R5, R6, and X are as defined herein. The compounds of Formula I have ALK and/or c-Met inhibitory activity, and may be used to treat ALK- or c-Met-mediated disorders or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.